Isosorbide mononitrate derivatives for the treatment of ocular hypertension

摘要

The present invention relates to the use of a compound of formula (I) or a tautomer, a pharmaceutically acceptable salt, a prodrug or a solvate thereof:
as active ingredient(s) in the manufacture of a pharmaceutical composition for the prevention and/or treatment of an ophthalmological disease mediated by ocular hypertension and/or an intestinal disorder.